Search filters
Filters
Clear All

Phase

  • 183
  • 156
  • 2
  • 194
  • 1
  • 148
  • 17
  • 396
  • 1237
  • 588
  • 29
  • 49
  • 3
  • 1162
  • 1237
  • 6
  • 3
  • 1240

Found 1243 All Conditions trials

A listing of All Conditions medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

V6.15 Smoke Testing (ST)

100 years or below
Accepts healthy volunteer
Male
Phase 3
Smoke testing
Check Eligibility
verification email study 8

verification email study 8

99 years or below
All genders
verification email study 8.
Learn More

Study on Heart Disease

5 years - 80 years
Accepts healthy volunteer
Female
Phase 2
This study investigates heart disease and focuses on understanding the condition better and evaluating potential treatment methods.Who can participate: The study is open to adults who have been diagnosed with heart disease.Study details: Participants will undergo medical assessments and provide health information to assist researchers in evaluating heart disease.
Check Eligibility
Perceptions of Vaping Products

Perceptions of Vaping Products

21 years - 34 years
Accepts healthy volunteer
All genders
This clinical trial studies the effects, appeal, and abuse liability of 6-methyl nicotine (metatine) electronic cigarettes among young adults.
Learn More

Trial for Type 2 Diabetes

18 years - 100 years
All genders
A study to evaluate the effectiveness of XYZ drug for Type 2 Diabetes treatment.
Learn More

Test study for the Auto update sync (SSRA)

10 years - 99 years
Male
Phase 1
verification email study 2
Learn More

Auto Update Toggle Tetsing

10 years - 8 years
All genders
verification email study 2
Check Eligibility

two NCT

99 years or below
All genders
See protocol section 2 See protocol section 2 See protocol section 2
Learn More

Test irb sync may 27 2025

99 years or below
All genders
verification email study 2
Learn More

ONC-108

99 years or below
All genders
To evaluate the efficacy of ONC201 administered following radiotherapy in participants with H3 K27Mmutant diffuse glioma. To assess plasma concentrations and estimate PK parameters for ONC201. To evaluate the efficacy of ONC201 using RANO-LGG criteria. To evaluate the impact of ONC201 treatment on health care resource utilization.
Learn More
781 - 790 of 1243